Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 8Phase 3 4Phase 1 4Phase 4 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 37Completed 26Recruiting 8Withdrawn 3Terminated 3Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 62INDUSTRY 20OTHER_GOV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1Recurrence 1Pain, Intractable 1Opportunistic Infections 1Nausea 1Inflammation 1Hepatitis C, Chronic 1Epstein-Barr Virus Infections 1Dizziness 1Cytomegalovirus Infections 1Coinfection 1Carcinoma, Hepatocellular 1Cancer Pain 1Acquired Immunodeficiency Syndrome 1

Interventions

ledipasvir 1dolutegravir 1Sofosbuvir 1Ritonavir 1Ribavirin 1Nucleosides 1Darunavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × OTHER_GOV × Clear all
NCT03639415 2021-03-08

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

Fujian Cancer Hospital

Phase 4 Withdrawn

Cancer Pain, Dizziness, Nausea, Pain, Intractable, Vomiting

NCT04183738 2020-11-10

i2-D²EFT

Kirby Institute

Phase 4 Withdrawn

Acquired Immunodeficiency Syndrome, Cytomegalovirus Infections, Inflammation, Opportunistic Infections, Epstein-Barr Virus Infections, Coinfection

NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡